| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.025 | 0.4 |
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.4 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.042 | 0.4 |
| mRNA | pandacostat | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.4 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.4 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |